A23L 33/135
Bacteria or derivatives thereof
Official title: Bacteria or derivatives thereof, e.g. probiotics
A23L33/135 (Bacteria or derivatives thereof) appears on 1,804 US grants and 3,880 published applications in this corpus.
Search patents in A23L- Granted patents
- 1,804
- Published applications
- 3,880
- Assignees
- 1,392
- Inventors
- 6,510
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 3 | 4 |
| 2003 | 5 | 19 |
| 2004 | 7 | 37 |
| 2005 | 7 | 42 |
| 2006 | 9 | 55 |
| 2007 | 16 | 53 |
| 2008 | 10 | 86 |
| 2009 | 18 | 76 |
| 2010 | 26 | 139 |
| 2011 | 30 | 118 |
| 2012 | 37 | 139 |
| 2013 | 65 | 140 |
| 2014 | 78 | 140 |
| 2015 | 75 | 170 |
| 2016 | 99 | 166 |
| 2017 | 106 | 180 |
| 2018 | 123 | 171 |
| 2019 | 109 | 246 |
| 2020 | 118 | 285 |
| 2021 | 142 | 318 |
| 2022 | 182 | 336 |
| 2023 | 151 | 303 |
| 2024 | 139 | 270 |
| 2025 | 137 | 230 |
| 2026 | 104 | 157 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oral and intestinal health products6 Oct 2026US 12,751,985 B2
- Fermented beverages and processes of preparing the same29 Sep 2026US 12,745,785 B2Compagnie Gervais Danone
- Use of E. coli strains expressing high level of α-Gal to modulate immunity and provide protection against infectious diseases in animals29 Sep 2026US 12,745,790 B2Biologicke Centrum AV CR v. v. i.
- Tea-based beverage22 Sep 2026US 12,740,576 B2National University of Singapore
- Synergistic blends of probiotics expressing improved beneficial activity for human host favourably interacting with food, particularly baby food22 Sep 2026US 12,740,583 B2Coree S.R.L.
- Oral dose compositions of tributyrin for the generation of butyrate in the gut8 Oct 2026US 2026/0305669 A1NutriScience Innovations LLC
- Method of addressing alzheimer's disease or non-alzheimer's dementia8 Oct 2026US 2026/0305670 A1G. Nofar Food Agency Ltd.
- Enhancer of number of tcr clones8 Oct 2026US 2026/0306562 A1Kabushiki Kaisha Yakult Honsha
- Nutritional composition1 Oct 2026US 2026/0293956 A1Societe des Produits Nestle S. A.
- Human milk oligosaccharides24 Sep 2026US 2026/0283208 A1Chr. Hansen A/S
Most cited
By later US patents
- Synergistic bacterial compositions and methods of production and use thereof242US 9,028,841 B2Seres Health, Inc. · 2015
- Probiotic recolonisation therapy240US 8,460,648 B22013
- Synergistic bacterial compositions and methods of production and use thereof138US 8,906,668 B2Seres Health, Inc. · 2014
- Probiotic recolonisation therapy117US 9,408,872 B2Crestovo LLC · 2016
- Bacterium for use as a probiotic for nutritional and medical applications104US 9,314,489 B24D Pharma Research Limited · 2016